TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹235 Cr | ₹101 Cr | ₹-142 Cr | ₹-300 Cr | ₹-422 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹235 Cr |
| Mar2024 | ₹101 Cr |
| Mar2023 | ₹-142 Cr |
| Mar2022 | ₹-300 Cr |
| Mar2021 | ₹-422 Cr |
How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹235 Cr | 132.43 | |
| Mar2024 | ₹101 Cr | Positive | |
| Mar2023 | ₹-142 Cr | Negative | |
| Mar2022 | ₹-300 Cr | Negative | |
| Mar2021 | ₹-422 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹145,395.3 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
| MANKIND PHARMA | ₹83,401.6 Cr | 1% | -1.3% | -11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.1% |
-0.4% |
31.8% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses